Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Nike: Rip The Script
It was all going to plan until footballer’s instincts took over.
Did Timothée Chalamet Just Take a Dig at Deceptive Marketing?
Why I’m a fan of this Adidas World Cup ad.
‘Bet Now’: How Wagering Apps’ Push Notification Ads Bombard Consumers
TINA.org joins petition urging FTC to require consent and opt-out for gambling marketing.
Does Gatorade ‘Hydrate Better than Water’?
Lawsuits takes aim at sports drinks’ superior hydration claim.
Phoebe Gates’s Startup Phia Was Just Accused of ‘Cookie Stuffing.’ Here’s What Happens Next
Esther Lian, Inc.com